Related Experiment Video
Updated: Jun 27, 2026

A General Method for Evaluating Deep Brain Stimulation Effects on Intravenous Methamphetamine Self-Administration
Published on: January 22, 2016
Secretory vesicle rebound hyperacidification and increased quantal size resulting from prolonged methamphetamine
Dmitriy Markov1, Eugene V Mosharov, Wanda Setlik
1Department of Neurology, Columbia University, College of Physicians and Surgeons, New York, NY 10032, USA.
Prolonged exposure to methamphetamine (METH) causes secretory vesicles to become hyperacidified. This compensatory response can enhance catecholamine release, contrary to acute amphetamine (AMPH) effects.
Area of Science:
- Neuroscience
- Cell Biology
- Pharmacology
Background:
- Acute amphetamine (AMPH) exposure disrupts secretory vesicle pH, affecting catecholamine release.
- Methamphetamine (METH) and AMPHs are retained in tissues long-term, suggesting different chronic effects.
Purpose of the Study:
- To investigate the long-term effects of METH on secretory vesicle pH and neurosecretion.
- To determine the impact of chronic METH exposure on catecholamine release from chromaffin cells.
Main Methods:
- Utilized optical and electron microscopy to assess vesicle pH.
- Employed amperometry and intracellular patch electrochemistry to monitor neurosecretion and cytosolic catecholamines.
- Cultured rat chromaffin cells were used to model METH exposure.
Main Results:
- Prolonged METH exposure (6-48h) induced a concentration-dependent rebound hyperacidification of secretory vesicles.
- At 5-10 microM, chronic METH increased quantal size and reinstated exocytotic catecholamine release.
- Rebound hyperacidification was temperature-dependent and occurred with other weak bases, indicating a compensatory mechanism.
Conclusions:
- Chronic METH exposure, unlike acute exposure, can enhance catecholamine release through vesicle hyperacidification.
- This compensatory mechanism is a general response to prolonged exposure to membranophilic weak bases.
- Under specific chronic exposure conditions, AMPHs can enhance rather than deplete vesicular catecholamine release.
Related Concept Videos
Desensitization and Tachyphylaxis
Several...
Drug Abuse and Addiction: Pharmacological Phenomena
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Overview of Secretory Vesicles
Various proteins regulate the aggregation of molecules inside the secretory vesicles. Chromogranins...
Drug Elimination by Renal Route: Tubular Reabsorption
Insulin Secretory Vesicles

